People don’t come to work every day to make money for shareholders, observes Vir Biotechnology president and CEO George Scangos. In biotech, he finds, most teams are instead motivated by the prospect of improving peoples’ lives. Consequently, he argues, his role as CEO is not to focus exclusively on maximizing shareholder returns, but to also think about responsibilities to other stakeholders, including patients, employees, the community and the environment.
Related

Elise Densborn,
Splendid Spoon
From Customer to Co-CEO [Entire Talk]
Passion for a brand or industry can be an incredible starting point for gaining entrepreneurial experience.
Video
45 minutes
Elise Densborn,
Splendid Spoon
From Customer to Co-CEO [Entire Talk]
Passion for a brand or industry can be an incredible starting point for gaining entrepreneurial experience.

Dante Disparte,
Circle
Ethical Crypto Innovation [Entire Talk]
To build a better crypto industry, start with ethics.
Video
48 minutes
Dante Disparte,
Circle
Ethical Crypto Innovation [Entire Talk]
To build a better crypto industry, start with ethics.

Ursheet Parikh,
Mayfield
Trevor Martin,
Mammoth Biosciences
Building Biotech to Last [Entire Talk]
The keys to future success must be established at the beginning of a platform biotech company.
Video
47 minutes
Ursheet Parikh,
Mayfield
Trevor Martin,
Mammoth Biosciences
Building Biotech to Last [Entire Talk]
The keys to future success must be established at the beginning of a platform biotech company.